Skip to content

In the BioHarmony Drug Report Database

Darbepoetin alfa

Aranesp (darbepoetin alfa) is a protein pharmaceutical. Darbepoetin alfa was first approved as Aranesp on 2001-06-08. It is used to treat anemia in the USA. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms.
Trade Name Aranesp
Common Name Darbepoetin alfa
Indication anemia, chronic kidney failure, neoplasms
Drug Class Erythropoietins
Darbepoetin alfa
Get full access now